Showing results (21-30 of 1,435) with videos related to
Sort By:
Pageof 144
Atherosclerosis. Supplements|January 30, 2013
Differences in the atherogenic risk of patients treated by lipoprotein apheresis according to their lipid patternM von Dryander, S Fischer, J Passauer, et al.Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|September 3, 2003
Influence of plasma free fatty acids on lipoprotein synthesis and diabetic dyslipidemiaU JuliusVersicherungsmedizin|April 1, 1995
[Blood coagulation/fibrinolytic disorders in diabetic patients]U JuliusExperimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|May 15, 2003
Fat modification in the diabetes dietU JuliusAtherosclerosis. Supplements|January 30, 2013
Regular lipoprotein apheresis maintains residual cardiovascular and microvascular function in patients with advanced atherosclerotic diseaseM Reimann, U Julius, S R Bornstein, et al.Atherosclerosis. Supplements|January 30, 2013
Lipoprotein apheresis reduces adipocyte fatty acid-binding protein serum levelsV Lamounier-Zepter, C Look, M Ehrhart-Bornstein, et al.Klinische Wochenschrift|December 1, 1987
Loss of fat, water, and protein during very low calorie diets and complete starvationM Weck, S Fischer, M Hanefeld, et al.Diabetes Care|April 1, 1991
Diabetes Intervention Study. Multi-intervention trial in newly diagnosed NIDDMM Hanefeld, S Fischer, H Schmechel, et al.Acta Diabetologica|October 3, 2002
Insulin-resistant patients with type 2 diabetes mellitus have higher serum leptin levels independently of body fat massS Fischer, M Hanefeld, S M Haffner, et al.Diabetologia|December 1, 1996
Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-upM Hanefeld, S Fischer, U Julius, et al.Pageof 144